ERalpha17p is a GPER inverse agonist, corresponding to residues 295-311 of the human estrogen receptor alpha (ERalpha). This 295-311 region is targeted by post-translational modifications and is involved in the recruitment of Ca2+-calmodulin, Hsp70 and the ubiquitin
